Search filters

List of works by Steven R Zeldenrust

A 71-Year-Old Woman with Multiple Myeloma Status after Stem Cell Transplantation

scientific article published on 01 December 2011

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision?

scientific article published on June 2013

A new test for detection ot the His 58 variant transthyretin allele in hereditary amyloidosis; creation of diagnostic restriction endonuclease recognition sites by PCR based mutagenesis

A new transthyretin variant (His 69) associated with vitreous amyloid in an FAP family

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

scientific article published on 13 July 2006

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 5 January 2006

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

scientific article

Acute renal failure after treatment with sunitinib in a patient with multiple myeloma

scientific article published on 15 April 2009

An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum

article

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma

scientific article published on 12 April 2018

Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.

scientific article published in April 2008

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

scientific article published on 20 July 2010

Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

scientific article

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

scientific article published on 25 February 2020

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis

scientific article published on 15 February 2011

Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry.

scientific article published on 16 November 2016

Clinical characteristics and outcomes in biclonal gammopathies

scientific article published on 3 February 2016

Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics

scientific article

Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma

scientific article

Clinical implication of centrosome amplification in plasma cell neoplasm

scientific article published on 22 December 2005

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

scientific article published on 29 April 2009

Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia

scientific article published on 29 March 2017

Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis

scientific article published on 21 October 2013

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

scientific article published on 23 August 2005

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

scientific article published on 09 October 2019

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

scientific article published on 14 August 2017

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria

scientific article published on 20 February 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization fourier-transform ion-cyclotron-resonance mass spectrometry

scientific article

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

scientific article published on 16 May 2019

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

scientific article published on 05 January 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

scientific article

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

scientific article published on 25 October 2017

Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma

scientific article

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

scientific article

Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry

scientific article

Familial and Senile Amyloidosis Caused by Transthyretin

Genotype – phenotype correlation in FAP

Genotype, echocardiography, and survival in familial transthyretin amyloidosis.

scientific article published on 16 October 2013

Getting to the heart of the matter: cardiac involvement in transthyretin-related amyloidosis

scientific article published on August 26, 2012

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

scientific article published on 9 February 2017

Hereditary ATTR amyloidosis: a single-institution experience with 266 patients

scientific article published on 27 May 2015

Histiocytes containing immunoglobulin crystals in the urine of a patient with IgA kappa plasmacytoma of the bladder

scientific article published in July 2004

Hodgkin's lymphoma manifesting with hypoglycemia.

scientific article

Identification of transthyretin variants by sequential proteomic and genomic analysis.

scientific article published on 24 June 2004

Immunoglobulin D amyloidosis: a distinct entity

scientific article published on 07 November 2011

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

scientific article published on 16 June 2016

Impact of acquired del(17p) in multiple myeloma

scientific article published on 01 July 2019

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis

scientific article published on 21 December 2017

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

scientific article published on 26 March 2009

Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma

scientific article

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

scientific article published on 26 January 2017

Improved survival in multiple myeloma and the impact of novel therapies

scientific article

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

scientific article published on February 2009

Induction of heme oxygenase-1 and ferritin in the kidney in warm antibody hemolytic anemia

scientific article published on 21 September 2008

Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation

scientific article published on 24 June 2016

Isolated amyloidosis presenting with lumbosacral radiculoplexopathy: description of two cases and pathogenic review

scientific article published on December 2006

Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis

scientific article published on 16 January 2015

Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction

scientific article

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

scientific article

Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial

scientific article published on 31 May 2011

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

scientific article

Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy

scientific article published on 18 February 2014

Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience

scientific article published on 11 March 2016

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

scientific article

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

scientific article published on 08 January 2020

Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation

scientific article published on 4 May 2011

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

scientific article published in October 2007

Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma

scientific article

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

scientific article published on April 2013

Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.

scientific article

Mass spectrometry analysis reveals non-mutated apolipoprotein A1 lumbosacral radiculoplexus amyloidoma.

scientific article

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

scientific article published on August 2006

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

scientific article published on 10 August 2016

Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System

scientific article

Natural history of amyloidosis isolated to fat and bone marrow aspirate.

scientific article published on 22 June 2016

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Neurolymphomatosis: A report of 2 cases representing opposite ends of the clinical spectrum.

scientific article published on 14 May 2015

OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS.

scientific article published on 24 October 2017

Ocular Manifestations of Familial Transthyretin Amyloidosis

scientific article published on 11 September 2017

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Outcome of liver transplantation for familial amyloidotic polyneuropathy

scientific article published in December 2003

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.

scientific article published on 2 March 2014

Outcomes of patients with POEMS syndrome treated initially with radiation

scientific article

Outcomes of patients with renal monoclonal immunoglobulin deposition disease

scientific article published on 8 August 2016

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

scientific article published on 8 March 2017

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Pitfalls in the diagnosis of primary amyloidosis

scientific article published on June 2010

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

scientific article published on 20 June 2011

Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis

scientific article

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

scientific article published on 5 May 2017

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

scientific article published on 08 February 2019

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis

scientific article published on 21 February 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

scientific article published on 30 April 2019

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

scientific article published on 25 March 2004

Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).

scientific article published in August 2012

Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy

scientific article published on September 2009

Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score

scientific article

Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma

scientific article published on 06 March 2016

Reply

scientific article published on 13 December 2017

Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial

scientific article

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

scientific article published on 13 February 2012

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

scientific article

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

scientific article published in September 2004

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

scientific article

Serum uric acid: novel prognostic factor in primary systemic amyloidosis

scientific article

Smoldering multiple myeloma requiring treatment: time for a new definition?

scientific article

Solid organ transplantation for non-TTR hereditary amyloidosis: report from the 1st International Workshop on the Hereditary Renal Amyloidoses

scientific article published on 27 April 2012

Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T.

scientific article

Some unusual complications of malignancies: case 2. Marantic endocarditis in advanced cancer

scientific article published on 01 October 2002

Substratification of patients with newly diagnosed standard-risk multiple myeloma

scientific article published on 15 February 2019

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

scientific article published on 22 January 2004

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome

scientific article published on October 2016

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 19 March 2013

Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides

scientific article published in May 2006

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

The Diflunisal Trial: study accrual and drug tolerance

scientific article published on 2 May 2012

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

scientific article

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation

scientific article published on 30 November 2015

The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS.

scientific article published on March 2011

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

scientific article published on 31 May 2017

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment

scientific article

The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome

scientific article published on 31 August 2011

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

scientific article published on 16 April 2018

Transition of Care for Inpatient Hematology Patients Receiving Chemotherapy: Development of Hospital Discharge Huddle Process and Effects of Implementation

scientific article published on 15 September 2015

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

scientific article published on 11 February 2009

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

scientific article published on August 2015

Treatment of immunoglobulin light chain amyloidosis

scientific article published on April 2009

Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement

scientific article published on March 2007

Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis

scientific article published on 17 March 2017

Trends and outcomes of modern staging of solitary plasmacytoma of bone

scientific article published on 2 May 2012

Trends in survival of patients with primary plasma cell leukemia: a population-based analysis

scientific article

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

scientific article published on 10 January 2012

Two causes of demyelinating neuropathy in one patient: CMT1A and POEMS syndrome

scientific article published on 01 August 2007

Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases

scientific article

Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis

scientific article published on 02 March 2014